Your browser is no longer supported. Please, upgrade your browser.
Settings
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.53 Insider Own1.00% Shs Outstand172.99M Perf Week2.38%
Market Cap4.39B Forward P/E- EPS next Y-0.92 Insider Trans61.28% Shs Float164.32M Perf Month8.22%
Income-210.10M PEG- EPS next Q-0.22 Inst Own71.60% Short Float14.46% Perf Quarter50.83%
Sales2.40M P/S1830.81 EPS this Y-135.30% Inst Trans0.81% Short Ratio9.00 Perf Half Y64.19%
Book/sh0.44 P/B57.73 EPS next Y27.00% ROA-98.60% Target Price36.00 Perf Year181.28%
Cash/sh2.07 P/C12.25 EPS next 5Y- ROE- 52W Range7.17 - 26.48 Perf YTD57.18%
Dividend- P/FCF- EPS past 5Y-44.67% ROI-200.90% 52W High-4.08% Beta1.73
Dividend %- Quick Ratio3.90 Sales past 5Y-37.60% Gross Margin72.70% 52W Low254.25% ATR0.94
Employees138 Current Ratio3.90 Sales Q/Q-61.50% Oper. Margin- RSI (14)64.11 Volatility2.49% 3.81%
OptionableYes Debt/Eq2.78 EPS Q/Q61.10% Profit Margin- Rel Volume0.49 Prev Close25.47
ShortableYes LT Debt/Eq2.78 EarningsAug 08 AMC Payout- Avg Volume2.64M Price25.40
Recom1.50 SMA204.03% SMA5011.18% SMA20053.87% Volume1,290,255 Change-0.27%
Jun-07-18Initiated B. Riley FBR, Inc. Buy $53
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Aug-31-11Initiated Summer Street Research Buy $8
Jul-28-11Initiated Summer Street Research Buy $8
Jul-13-11Resumed Brean Murray Buy $8
May-17-11Initiated Oppenheimer Outperform $6
Feb-23-11Initiated Wedbush Outperform $6
Jul-03-07Initiated Brean Murray Buy $8
Feb-20-07Initiated Lazard Capital Buy $6
Jul-18-18 08:00AM  FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative Breast Cancer GlobeNewswire
Jul-11-18 07:35AM  Complimentary Technical Snapshots on Incyte and Three More Biotech Stocks ACCESSWIRE
Jun-27-18 10:42AM  How Financially Strong Is Immunomedics Inc (NASDAQ:IMMU)? Simply Wall St.
Jun-21-18 04:42PM  [$$] Immunomedics Chairman Buys $19M More in Stock Barrons.com
08:20AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Immunomedics ACCESSWIRE
Jun-15-18 11:39AM  Immunomedics Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-13-18 08:00AM  Immunomedics Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-12-18 02:30PM  The Charts of Immunomedics Look Very Bullish Now TheStreet.com
08:47AM  Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate Benzinga
Jun-11-18 04:13PM  Immunomedics Announces Proposed Public Offering of Common Stock GlobeNewswire
03:48PM  After-hours buzz: RH, PLAY and more CNBC
Jun-05-18 08:49AM  Immunomedics (IMMU) Soars: Stock Adds 10.3% in Session Zacks
08:20AM  Today's Research Reports on Stocks to Watch: Genomic Health and Immunomedics ACCESSWIRE
Jun-04-18 04:33PM  Why Fossil Group, Companhia Siderurgica Nacional, and Immunomedics Jumped Today Motley Fool +10.26%
04:32PM  Why A Tie-Up With Clovis Helped This Biotech Spike To An 18-Year High Investor's Business Daily
03:20PM  Why Data at ASCO 2018 Sent Immunomedics Shares Soaring Today Motley Fool
01:18PM  5 Biotech Stocks Moving On ASCO Presentations Benzinga
08:00AM  Immunomedics Provides Business Update at the ASCO 2018 Investor Event GlobeNewswire
Jun-03-18 08:00PM  Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers GlobeNewswire
10:15AM  Immunomedics Reveals Promising Data for Sacituzumab Govitecan in Patients Heavily Pretreated for Metastatic Estrogen Receptor-Positive Breast Cancer GlobeNewswire
Jun-01-18 08:00AM  Immunomedics Announces Pivotal Study of Sacituzumab Govitecan in Patients With Locally Advanced or Metastatic Urothelial Cancer GlobeNewswire
May-30-18 08:00AM  Immunomedics to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-21-18 08:00AM  Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration GlobeNewswire
May-18-18 04:03AM  Edited Transcript of IMMU earnings conference call or presentation 9-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-17-18 12:43PM  Immunomedics Inc (NASDAQ:IMMU): Time For A Financial Health Check Simply Wall St. +7.12%
08:00AM  Today's Research Reports on Trending Tickers: Immunomedics and Rite Aid ACCESSWIRE
May-16-18 05:01PM  Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer GlobeNewswire
May-09-18 04:24PM  Immunomedics: Fiscal 3Q Earnings Snapshot Associated Press
04:00PM  Immunomedics Announces Third Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
07:30AM  Analysis: Positioning to Benefit within Entergy, Schneider National, C.H. Robinson Worldwide, PTC Therapeutics, Guess?, and Immunomedics  Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-02-18 12:01PM  Harry Boxers four biotech stocks to watch today MarketWatch
08:00AM  Immunomedics to Report Third Quarter Fiscal 2018 Results and Host Conference Call and Webcast on May 9, 2018 GlobeNewswire
May-01-18 08:45AM  Immunomedics (IMMU) in Focus: Stock Moves 7.9% Higher Zacks
08:10AM  Todays Research Reports on Stocks to Watch: Heat Biologics and Immunomedics ACCESSWIRE
Apr-25-18 12:15PM  Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
Apr-17-18 10:21AM  When Will Immunomedics Inc (NASDAQ:IMMU) Become Profitable? Simply Wall St.
Apr-13-18 08:20AM  Todays Research Reports on Trending Tickers: Exact Sciences and Immunomedics ACCESSWIRE
Apr-11-18 08:30AM  Todays Research Reports on Trending Tickers: Neuralstem and Immunomedics ACCESSWIRE
Apr-09-18 08:00AM  Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer GlobeNewswire
Mar-27-18 08:25AM  Todays Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Immunomedics ACCESSWIRE
Mar-05-18 08:00AM  Immunomedics to Present at Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Feb-26-18 06:06PM  Edited Transcript of IMMU earnings conference call or presentation 8-Feb-18 10:00pm GMT Thomson Reuters StreetEvents
Feb-15-18 08:00AM  Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference GlobeNewswire
07:30AM  Fennec Pharma (FENC): The Most Likely Acquisition Target in Healthcare with 200-300% Upside? ACCESSWIRE
Feb-14-18 07:30AM  Blog Exposure - FDA Accepts Amicus Therapeutics NDA for Migalastat for Treatment of Fabry Disease ACCESSWIRE
Feb-13-18 03:49PM  8 Companies That Could Disappear by 2019 InvestorPlace
Feb-09-18 05:01AM  Immunomedics reports 2Q loss Associated Press
Feb-08-18 04:15PM  Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
Feb-06-18 08:00AM  Immunomedics to Report Second Quarter Fiscal 2018 Results and Host Conference Call and Webcast on February 8, 2018 GlobeNewswire
Jan-31-18 08:20AM  New Research: Key Drivers of Growth for Cavco Industries, National Commerce, The Providence Service, Cisco, Immunomedics, and Emergent Biosolutions Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-17-18 07:00AM  Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock InvestorPlace
Jan-11-18 08:00AM  Immunomedics Announces Agreement with University of Wisconsin Carbone Cancer Center to Expand Sacituzumab Govitecan (IMMU-132) into Prostate Cancer GlobeNewswire
Jan-10-18 08:00AM  Todays Research Reports on Stocks to Watch: Immunomedics, Inc. and Axsome Therapeutics ACCESSWIRE
Jan-08-18 08:30AM  Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 Million GlobeNewswire
Jan-04-18 08:45AM  Immunomedics to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 11:34AM  Harry Boxer: These two marijuana stocks are climbing higher MarketWatch
Dec-22-17 11:41AM  ETFs with exposure to Immunomedics, Inc. : December 22, 2017 Capital Cube +6.08%
Dec-21-17 12:23PM  BlackBerry Among Four Stocks Breaking Out Forbes
Dec-13-17 07:02AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Immunomedics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Dec-11-17 01:59PM  ETFs with exposure to Immunomedics, Inc. : December 11, 2017 Capital Cube
Dec-08-17 01:59PM  5 Cheap Biotech Stocks to Snag on the Bounce InvestorPlace
07:45AM  Immunomedics' Data Is Good News for Seattle Genetics, Too Motley Fool
07:16AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : December 8, 2017 Capital Cube
Dec-07-17 08:10AM  Todays Research Reports on Stocks to Watch: Immunomedics and Valeant Pharmaceuticals ACCESSWIRE +16.16%
Dec-06-17 03:58PM  Why Immunomedics, Inc. Is Soaring Today Motley Fool +13.00%
12:10PM  Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) In Patients With Relapsed Or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC) GlobeNewswire
Nov-30-17 02:00PM  ETFs with exposure to Immunomedics, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:04AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017 Capital Cube
Nov-28-17 08:05AM  Immunomedics, Full Study Data to be Presented December 6, 2017, BLA Application as Early as 1Q18 ACCESSWIRE
Nov-27-17 08:05AM  Analysis: Positioning to Benefit within Aradigm, General Motors, AT&T, Denbury Resources, Novavax, and Immunomedics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-20-17 07:40AM  Featured Company News - Biohaven Pharma Completed Enrollment in First of Two Pivotal Phase-3 Clinical Trials of Rimegepant for Acute Treatment of Migraine ACCESSWIRE
Nov-16-17 08:43AM  Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock Zacks +8.11%
Nov-15-17 08:38AM  Immunomedics (IMMU) Jumps: Stock Rises 5.4% Zacks +5.31%
Nov-14-17 04:07PM  Edited Transcript of IMMU earnings conference call or presentation 9-Nov-17 10:00pm GMT Thomson Reuters StreetEvents +5.40%
12:44PM  Cowen Bets on Immunomedics Securing Accelerated Approval Even After Decreased Overall Survival Seen in IMMU-132 Abstract SmarterAnalyst
Nov-13-17 04:30PM  Why Sears Holdings, Immunomedics, and J.C. Penney Slumped Today Motley Fool -19.35%
09:30AM  Immunomedics Announces Presentations and Investor Event at the 2017 San Antonio Breast Cancer Symposium GlobeNewswire
07:24AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : November 13, 2017 Capital Cube
Nov-10-17 03:02PM  Why Immunomedics, Inc. Jumped Higher Today Motley Fool +18.77%
08:20AM  Todays Research Reports on Trending Tickers: Endo International and Immunomedics ACCESSWIRE
Nov-09-17 05:21PM  Immunomedics reports 1Q loss Associated Press
04:10PM  Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
04:05PM  Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth GlobeNewswire
01:00PM  Immunomedics, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-17 08:00AM  Immunomedics to Report First Quarter Fiscal 2018 Results and Host Conference Call and Webcast on November 9, 2017 GlobeNewswire +6.82%
Oct-31-17 12:13PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : October 31, 2017 Capital Cube -5.13%
11:42AM  ETFs with exposure to Immunomedics, Inc. : October 31, 2017 Capital Cube
Oct-30-17 08:11AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : October 30, 2017 Capital Cube
Oct-27-17 09:35AM  Versartis Drops on Q3 Numbers, Hires Adviser -- Biotech Movers TheStreet.com +6.18%
Oct-23-17 08:37AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Oct-05-17 12:21PM  Edited Transcript of IMMU earnings conference call or presentation 16-Aug-17 9:00pm GMT Thomson Reuters StreetEvents -8.50%
Oct-03-17 11:19AM  ETFs with exposure to Immunomedics, Inc. : October 3, 2017 Capital Cube
Sep-15-17 04:30PM  Why Carnival, Immunomedics, and Fitbit Slumped Today Motley Fool
08:00AM  Immunomedics Announces Agreements to Exchange Approximately $80.0 Million of Its 4.75% Convertible Senior Notes Due 2020 for Common Stock GlobeNewswire
Sep-11-17 09:00AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks +5.17%
07:00AM  Immunomedics Presents Interim Phase 2 Results With Sacituzumab Govitecan (IMMU-132) in Patients With Pretreated Metastatic Urothelial Cancer GlobeNewswire
Aug-30-17 08:00AM  Immunomedics to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-28-17 05:33PM  ETFs with exposure to Immunomedics, Inc. : August 28, 2017 Capital Cube +14.07%
03:30PM  Here's Why Immunomedics Rose as Much as 14.2% Today Motley Fool
Aug-24-17 12:51PM  Harry Boxer: These three biotech stocks are breaking out MarketWatch +9.88%
Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and IMMU-140 that targets HLA-DR for the potential treatment of liquid cancers. It also develops products for the treatment of cancer and autoimmune diseases, including epratuzumab, anti-CD22 antibody; veltuzumab, anti-CD20 antibody; milatuzumab, anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. The company also provides LeukoScan, a diagnostic imaging product to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody; and a collaboration agreement with University of Wisconsin Carbone Cancer Center to expand IMMU-132 into prostate cancer. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
venBio Select Advisor LLCDirectorJun 15Buy24.00575,00013,800,00017,514,461Jun 15 02:02 PM
venBio Select Advisor LLCDirectorJun 15Buy23.39200,0004,678,00017,714,461Jun 19 04:05 PM
GOLDENBERG DAVID MDirectorMar 07Sale17.6840,000707,0005,613,252Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorMar 07Sale17.5020,000350,0001,774,285Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorMar 05Sale17.2440,000689,4005,653,252Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorFeb 28Sale17.0917,729302,9895,693,252Mar 12 08:32 PM
MARKISON BRIAN ADirectorNov 20Option Exercise3.1615,00047,40099,178Nov 21 05:00 PM
MARKISON BRIAN ADirectorNov 20Sale11.898,39099,72490,788Nov 21 05:00 PM
venBio Select Advisor LLCDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 15 05:48 PM
venBio Select Advisor LLCDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 15 05:48 PM
GOLDENBERG CYNTHIA LDirectorSep 01Sale12.9010,000129,000778,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksSep 01Sale12.9010,000129,0003,395,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 31Sale12.3810,000123,750788,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksAug 31Sale12.3810,000123,7503,405,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 28Sale11.5215,000172,841798,219Aug 28 08:54 PM
GOLDENBERG DAVID MSee RemarksAug 28Sale11.5610,000115,5913,415,578Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 24Sale10.2425,000256,105813,219Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 23Sale9.5010,00095,000838,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 23Sale9.5010,00095,0003,455,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 22Sale9.5010,00095,000848,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 22Sale9.5010,00095,0003,465,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 21Sale8.9720,000179,426858,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 21Sale8.9720,000179,4263,475,578Aug 23 09:00 PM
HCI HCI Group, Inc. daily Stock Chart
HCI [NYSE]
HCI Group, Inc.
Index- P/E- EPS (ttm)-1.07 Insider Own11.70% Shs Outstand9.24M Perf Week1.85%
Market Cap386.14M Forward P/E9.19 EPS next Y4.55 Insider Trans0.00% Shs Float7.24M Perf Month-5.11%
Income-9.00M PEG- EPS next Q1.02 Inst Own76.50% Short Float11.19% Perf Quarter1.85%
Sales235.40M P/S1.64 EPS this Y-131.30% Inst Trans0.08% Short Ratio12.33 Perf Half Y22.19%
Book/sh23.87 P/B1.75 EPS next Y15.73% ROA- Target Price48.25 Perf Year-8.72%
Cash/sh24.48 P/C1.71 EPS next 5Y25.00% ROE- 52W Range27.11 - 47.58 Perf YTD39.77%
Dividend1.50 P/FCF- EPS past 5Y-18.10% ROI2.00% 52W High-12.17% Beta1.63
Dividend %3.59% Quick Ratio- Sales past 5Y8.50% Gross Margin- 52W Low54.15% ATR0.94
Employees410 Current Ratio- Sales Q/Q-14.90% Oper. Margin- RSI (14)49.02 Volatility1.61% 2.39%
OptionableYes Debt/Eq1.24 EPS Q/Q-16.50% Profit Margin- Rel Volume0.52 Prev Close41.52
ShortableYes LT Debt/Eq1.24 EarningsAug 01 AMC Payout- Avg Volume65.70K Price41.79
Recom2.20 SMA200.07% SMA50-0.60% SMA20012.33% Volume35,256 Change0.65%
Sep-11-17Upgrade Sidoti Neutral → Buy
Apr-07-17Initiated SunTrust Buy $52
Dec-28-15Initiated Piper Jaffray Overweight
Oct-20-15Upgrade JMP Securities Mkt Perform → Mkt Outperform $47
Mar-17-15Downgrade Gilford Securities Buy → Neutral $50
Oct-03-14Upgrade Gilford Securities Neutral → Buy $46.50 → $52
Oct-24-13Downgrade Gilford Securities Buy → Neutral $44.50 → $45.60
Aug-30-13Upgrade Gilford Securities Neutral → Buy $37.50 → $44.50
Aug-02-13Reiterated Gilford Securities Neutral $36 → $37.50
May-28-13Downgrade Taglich Brothers Buy → Speculative Buy $22 → $38
May-08-13Downgrade Gilford Securities Buy → Neutral
Apr-01-13Reiterated Taglich Brothers Buy $27.35 → $31.95
Mar-06-13Reiterated Gilford Securities Buy $26 → $30
Jul-16-18 05:00PM  HCI Group Sets Second Quarter 2018 Earnings Call for Thursday, August 2, 2018 at 4:45 p.m. ET GlobeNewswire
Jul-06-18 08:00AM  HCI Group Declares Q3 2018 Regular Quarterly Cash Dividend GlobeNewswire
Jun-27-18 02:58PM  How shareholders had their say on pay at two of Tampa Bays biggest companies American City Business Journals
Jun-26-18 11:22AM  Allstate (ALL) Catastrophe Woes Continue With Losses in May Zacks
09:30AM  Is HCI Group (HCI) Outperforming Other Finance Stocks This Year? Zacks
Jun-18-18 10:34AM  Here's Why You Should Hold on to Hartford Financial Stock Zacks
Jun-06-18 01:51PM  Heres why property insurance premiums could be going up in Florida and in Tampa Bay American City Business Journals
08:00AM  HCI Group Completes its 2018-2019 CAT Reinsurance Program, Reduces Risk Retention GlobeNewswire
Jun-05-18 12:37PM  4 Best Value Bets From Undervalued P&C Insurance Industry InvestorPlace
May-29-18 09:34AM  Top Ranked Income Stocks to Buy for May 29th Zacks
May-21-18 08:20AM  Report: Exploring Fundamental Drivers Behind Syros Pharmaceuticals, J & J Snack Foods, Wright Medical Group N.V, HCI Group, Tennant, and Ebix New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
May-18-18 05:22PM  Edited Transcript of HCI earnings conference call or presentation 1-May-18 8:45pm GMT Thomson Reuters StreetEvents
May-01-18 06:22PM  HCI Group: 1Q Earnings Snapshot Associated Press
04:15PM  HCI Group Reports First Quarter 2018 Results GlobeNewswire
Apr-25-18 08:00AM  HCI Group Launches InsurTech Platform for Homeowners Insurance GlobeNewswire
Apr-18-18 09:34AM  HCI Group Rewards Shareholders With 7.1% Dividend Raise Zacks
Apr-17-18 08:00AM  HCI Group Increases Quarterly Cash Dividend 7.1% to 37.5 Cents GlobeNewswire
Apr-12-18 08:00AM  HCI Group InsurTech Platform Surpasses $10 Million GlobeNewswire
Apr-10-18 08:00AM  HCI Group Sets First Quarter 2018 Earnings Call for Tuesday, May 1, 2018 at 4:45 p.m. ET GlobeNewswire
Mar-23-18 07:35AM  Recent Analysis Shows Asbury Automotive Group, PJT Partners, eHealth, HCI Group, Getty Realty, and TPG Specialty Lending Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Mar-12-18 04:15PM  HCI Group Sets 2018 Annual Shareholders' Meeting and Record Date GlobeNewswire
Mar-07-18 08:21PM  Edited Transcript of HCI earnings conference call or presentation 6-Mar-18 9:45pm GMT Thomson Reuters StreetEvents +13.92%
10:31AM  HCI Group (HCI) Q4 Earnings Beat Estimates, Revenues In Line Zacks
Mar-06-18 06:37PM  HCI Group posts 4Q profit Associated Press
04:15PM  HCI Group Reports Fourth Quarter and Full Year 2017 Results GlobeNewswire
12:30PM  HCI Group, Inc. to Host Earnings Call ACCESSWIRE
08:19AM  At $36.66, Is It Time To Buy HCI Group Inc (NYSE:HCI)? Simply Wall St.
Feb-12-18 08:00AM  HCI Group Sets Fourth Quarter and Full Year 2017 Earnings Call for Tuesday, March 6, 2018 at 4:45 p.m. ET GlobeNewswire
Jan-24-18 08:30AM  Market Trends Toward New Normal in HCI Group, Mitek, Duluth, Gentherm, Masonite International, and AmeriGas Partners Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-22-18 08:00AM  HCI Group Declares Q1 2018 Regular Quarterly Cash Dividend GlobeNewswire
Jan-16-18 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in California GlobeNewswire
Dec-28-17 08:20AM  Year in Review: First Coast's tech successes in 2017 American City Business Journals
Dec-15-17 01:29PM  ETFs with exposure to HCI Group, Inc. : December 15, 2017 Capital Cube
Dec-12-17 08:00AM  HCI Group Appoints Karin Coleman to Executive Vice President GlobeNewswire
Dec-06-17 08:00AM  HCI Group Board Authorizes $20 Million Stock Repurchase Program for 2018 GlobeNewswire
Dec-05-17 12:56PM  ETFs with exposure to HCI Group, Inc. : December 5, 2017 Capital Cube
Dec-01-17 08:45AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017 Capital Cube
Nov-30-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Ohio GlobeNewswire
Nov-17-17 10:17AM  HCI Group, Inc. : HCI-US: Dividend Analysis : November 17th, 2017 (record date) : By the numbers : November 17, 2017 Capital Cube
Nov-07-17 07:34PM  Edited Transcript of HCI earnings conference call or presentation 2-Nov-17 8:45pm GMT Thomson Reuters StreetEvents
Nov-06-17 11:45AM  ETFs with exposure to HCI Group, Inc. : November 6, 2017 Capital Cube
05:38AM  HCI Group reports 3Q loss Associated Press
Nov-02-17 04:15PM  HCI Group Reports Third Quarter and Nine-Month 2017 Results GlobeNewswire
12:20PM  HCI Group, Inc. to Host Earnings Call ACCESSWIRE
Nov-01-17 08:27AM  HCI Group, Inc. breached its 50 day moving average in a Bearish Manner : HCI-US : November 1, 2017 Capital Cube
Oct-27-17 08:00AM  HCI Group Real Estate Division Acquires New Office Building GlobeNewswire
Oct-24-17 08:00AM  HCI Group Declares Q4 2017 Regular Quarterly Cash Dividend GlobeNewswire
Oct-20-17 09:17AM  New Strong Sell Stocks for October 20th Zacks
Oct-17-17 10:13AM  HCI Group, Inc. Value Analysis (NYSE:HCI) : October 17, 2017 Capital Cube
Oct-16-17 08:09AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : October 16, 2017 Capital Cube
Oct-09-17 08:00AM  HCI Group Sets Third Quarter 2017 Earnings Call for Thursday, November 2, 2017 at 4:45 p.m. ET GlobeNewswire
Oct-06-17 05:06PM  State Auto Financial (STFC) Projects Q3 Cat Loss Estimates Zacks
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in North Carolina GlobeNewswire
Sep-27-17 09:29AM  United Insurance (UIHC) Keeps a Count of Q3 Catastrophe Loss Zacks
Sep-25-17 04:00PM  Allstate Estimates Catastrophe Loss from Hurricane Harvey Zacks
Sep-21-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in New Jersey GlobeNewswire
Sep-19-17 10:33AM  HCI Group (HCI) Calculates Possible Irma Catastrophe Loss Zacks
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Texas GlobeNewswire
Sep-18-17 05:56PM  ETFs with exposure to HCI Group, Inc. : September 18, 2017 Capital Cube
08:00AM  HCI Group Insurance Subsidiaries Issue Loss Estimates from Hurricane Irma GlobeNewswire
Sep-15-17 03:16PM  HCI Group, Inc. : HCI-US: Dividend Analysis : August 18th, 2017 (record date) : By the numbers : September 15, 2017 Capital Cube
11:51AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 15, 2017 Capital Cube
Sep-12-17 05:00PM  Universal Insurance and other big Florida insurers see a quick rebound in stock prices American City Business Journals
Sep-11-17 08:05AM  How Tampa Bay and Florida insurers are making it through the storm American City Business Journals +17.48%
Sep-08-17 01:40PM  Hurricane Irma causes Florida insurance stocks to plunge American City Business Journals
10:22AM  The Zacks Analyst Blog Highlights: HCI Group, Lumber Liquidators, Tempur Sealy International and Home Depot Zacks
Sep-07-17 04:30PM  Hurricane Irma: These Insurance Stocks Have the Most Exposure to Florida Zacks -8.46%
08:48AM  HCI Group (HCI) in Focus: Stock Moves 5.8% Higher Zacks
Sep-06-17 11:08AM  ETFs to Watch in Harvey Aftermath & New Hurricane Irma Zacks +5.79%
Sep-05-17 03:25PM  Irma batters Tampa Bay insurance stocks American City Business Journals -20.01%
Aug-25-17 08:15AM  HCI Group to Participate at the 6th Annual Liolios Gateway Conference and the 2017 KBW Insurance Conference in September 2017 GlobeNewswire
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in South Carolina GlobeNewswire
Aug-23-17 08:34AM  Liolios Releases Presenting Company Roster for its 6th Annual Gateway Conference on September 6-7 in San Francisco GlobeNewswire
Aug-17-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Maryland GlobeNewswire
Aug-12-17 01:50AM  Edited Transcript of HCI earnings conference call or presentation 2-Aug-17 8:45pm GMT Thomson Reuters StreetEvents
Aug-04-17 03:22AM  HCI Group posts 2Q profit Associated Press
Aug-02-17 04:15PM  HCI Group Reports Second Quarter and Six-Month 2017 Results GlobeNewswire
Aug-01-17 04:10PM  Investor Network Invites You to the HCI Group Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 2, 2017 ACCESSWIRE
Jul-31-17 06:25PM  HCI Group, Inc. Value Analysis (NYSE:HCI) : July 31, 2017 Capital Cube
Jul-17-17 09:48AM  HCI Group, Inc. breached its 50 day moving average in a Bearish Manner : HCI-US : July 17, 2017 Capital Cube
Jul-14-17 08:05AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Pennsylvania GlobeNewswire
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Arkansas GlobeNewswire
Jul-10-17 08:00AM  HCI Group Declares Q3 2017 Regular Quarterly Cash Dividend GlobeNewswire
Jun-22-17 08:00AM  HCI Group Insurance Subsidiaries Expand Flood Insurance into Nine Additional States GlobeNewswire
Jun-13-17 04:15PM  HCI Group to Participate at the JMP Financial Services and Real Estate Conference on Thursday, June 22, 2017 GlobeNewswire
Jun-12-17 02:07PM  ETFs with exposure to HCI Group, Inc. : June 12, 2017 Capital Cube
Jun-09-17 09:46AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017 Capital Cube
08:10AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : June 9, 2017 Capital Cube
Jun-01-17 08:30AM  HCI Group Insurance Subsidiary, Homeowners Choice, Improves Coverage and Reduces Risk GlobeNewswire
May-19-17 12:11PM  HCI Group, Inc. : HCI-US: Dividend Analysis : May 19th, 2017 (record date) : By the numbers : May 19, 2017 Capital Cube
May-10-17 07:05PM  Edited Transcript of HCI earnings conference call or presentation 4-May-17 8:45pm GMT Thomson Reuters StreetEvents
May-05-17 05:03AM  HCI Group posts 1Q profit Associated Press
May-04-17 04:15PM  HCI Group Reports First Quarter 2017 Results GlobeNewswire
May-03-17 04:10PM  Investor Network Invites You to the HCI Group First Quarter 2017 Earnings Conference Call and Webcast Live on Thursday, May 4, 2017 Accesswire
Apr-26-17 08:22AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : April 26, 2017 Capital Cube
Apr-24-17 03:10PM  Heres what happened when HCI Groups biggest shareholder bought more stock American City Business Journals
08:00AM  HCI Group Terminates Shareholder Rights Plan GlobeNewswire
Apr-19-17 08:00AM  HCI Group Declares Q2 2017 Regular Quarterly Cash Dividend GlobeNewswire
Apr-17-17 08:00AM  HCI Group Sets First Quarter 2017 Earnings Call for Thursday, May 4, 2017 at 4:45 p.m. ET GlobeNewswire
Apr-12-17 08:05AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : April 12, 2017 Capital Cube
HCI Group, Inc. primarily engages in the property and casualty insurance business in Florida. It provides property and casualty insurance to homeowners, condominium owners, and tenants; and reinsurance. The company also owns and operates one full-service restaurant, two marinas, two retail shopping centers, and one office building. In addition, it offers designs and develops Web-based applications and products for mobile devices. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Politis GregoryDirectorDec 19Buy29.102,00058,200196,000Dec 21 04:03 PM
Politis GregoryDirectorDec 18Buy29.972,00059,946194,000Dec 19 03:51 PM
Politis GregoryDirectorDec 15Buy29.282,00058,552192,000Dec 19 03:51 PM
Patel PareshChief Executive OfficerDec 08Buy30.301,00030,30035,000Dec 12 03:50 PM
Macchiarola James JDirectorNov 27Buy30.446,000182,6236,000Nov 29 03:55 PM
Harmsworth James MarkChief Financial OfficerSep 21Buy36.9350018,467500Sep 21 04:33 PM
Graham Andrew L.GC/Corporate SecretarySep 21Buy36.45652,3692,825Sep 21 04:31 PM
Patel PareshChief Executive OfficerSep 20Buy36.061,00036,062285,000Sep 21 04:29 PM
HSKA Heska Corporation daily Stock Chart
HSKA [NASD]
Heska Corporation
Index- P/E60.01 EPS (ttm)1.79 Insider Own4.40% Shs Outstand7.26M Perf Week2.63%
Market Cap781.61M Forward P/E53.32 EPS next Y2.02 Insider Trans-10.70% Shs Float6.71M Perf Month1.08%
Income13.40M PEG2.40 EPS next Q0.16 Inst Own90.20% Short Float8.61% Perf Quarter35.49%
Sales131.70M P/S5.93 EPS this Y45.30% Inst Trans0.03% Short Ratio8.78 Perf Half Y33.89%
Book/sh14.80 P/B7.27 EPS next Y21.85% ROA5.60% Target Price116.50 Perf Year5.01%
Cash/sh1.67 P/C64.60 EPS next 5Y25.00% ROE7.40% 52W Range56.59 - 115.00 Perf YTD34.22%
Dividend- P/FCF79.76 EPS past 5Y56.80% ROI14.30% 52W High-6.38% Beta0.80
Dividend %- Quick Ratio1.40 Sales past 5Y12.20% Gross Margin44.30% 52W Low90.25% ATR3.42
Employees345 Current Ratio2.70 Sales Q/Q10.80% Oper. Margin13.10% RSI (14)55.27 Volatility2.37% 3.91%
OptionableNo Debt/Eq0.06 EPS Q/Q-53.90% Profit Margin5.70% Rel Volume0.25 Prev Close107.68
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout0.00% Avg Volume65.75K Price107.66
Recom2.00 SMA202.06% SMA504.53% SMA20024.75% Volume16,709 Change-0.02%
May-18-18Reiterated Canaccord Genuity Buy $100 → $115
May-18-18Reiterated B. Riley FBR, Inc. Neutral $77 → $93
May-07-18Reiterated The Benchmark Company Buy $90 → $100
Mar-01-18Reiterated B. Riley FBR, Inc. Neutral $93 → $77
Feb-05-18Upgrade Sidoti Neutral → Buy $94
Nov-03-17Reiterated B. Riley FBR, Inc. Neutral $96.50 → $93
Aug-03-17Reiterated The Benchmark Company Buy $106 → $120
Mar-01-17Reiterated The Benchmark Company Buy $100 → $106
Jan-26-17Downgrade CL King Buy → Neutral
Nov-29-16Initiated The Benchmark Company Buy $78
Aug-04-16Downgrade Gabelli & Co Buy → Hold
Jul-01-16Initiated Sidoti Buy
Apr-01-16Initiated CL King Buy
Dec-12-14Initiated Gabelli & Co Buy $20
Aug-08-13Reiterated Feltl & Co. Strong Buy $12.50 → $9.50
Sep-11-12Initiated Feltl & Co. Strong Buy $13.50
Aug-13-12Downgrade C.K. Cooper Buy → Hold
Jun-08-12Initiated C.K. Cooper Buy $20
Jul-18-18 08:00AM  Heska Schedules Second Quarter 2018 Financial Results Conference Call for August 7, 2018 PR Newswire
Jul-16-18 04:35PM  As America's hiring spree continues, these Denver companies are leading the charge American City Business Journals
Jul-09-18 07:54AM  New Strong Sell Stocks for July 9th Zacks
Jun-22-18 03:31PM  Does Heska Corporations (NASDAQ:HSKA) PE Ratio Signal A Selling Opportunity? Simply Wall St.
Jun-14-18 04:05PM  Pathway Vet Alliance, Heska Corporation announce multi-year strategic partnership aimed at elevating veterinary care nationwide PR Newswire
May-24-18 07:50AM  Recent Analysis Shows Alexander's, American National Insurance, VAREX IMAGING, Banner, Instructure, and Heska Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-17-18 07:40AM  Wired News Heska Collaborates with MBio Diagnostics for Developing New Products for the Veterinary Market ACCESSWIRE
May-08-18 05:50PM  Edited Transcript of HSKA earnings conference call or presentation 4-May-18 3:00pm GMT Thomson Reuters StreetEvents
May-04-18 08:09AM  Heska: 1Q Earnings Snapshot Associated Press +5.07%
08:00AM  Heska Reports First Quarter Results PR Newswire
May-03-18 08:42AM  Why Heska (HSKA) Might Surprise This Earnings Season Zacks
08:00AM  Heska to Present at Upcoming Conferences in May & June 2018 PR Newswire
May-02-18 03:34PM  Heska Corporation Announces Board Action PR Newswire
08:00AM  Heska to Host Analyst and Investor Day on May 15 PR Newswire
Apr-30-18 08:00AM  Heska Names EVP, International Diagnostics, to Accelerate International Expansion PR Newswire
Apr-25-18 08:00AM  Heska Confirms Details for Annual Meeting of Stockholders on May 3, 2018 PR Newswire
Apr-10-18 08:00AM  Heska Schedules First Quarter 2018 Financial Results Conference Call for May 4, 2018 PR Newswire
Apr-06-18 08:00AM  Heska Schedules Annual Meeting of Stockholders for May 3, 2018 PR Newswire
Apr-02-18 07:30AM  Research Report Identifies Werner Enterprises, Midland States, First, German American, Heska, and Sigma Designs with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-02-18 06:05AM  Edited Transcript of HSKA earnings conference call or presentation 28-Feb-18 4:00pm GMT Thomson Reuters StreetEvents
Feb-28-18 09:03AM  Heska reports 4Q loss Associated Press +13.89%
08:50AM  Heska Corporation to Host Earnings Call ACCESSWIRE
07:00AM  Heska Reports Fourth Quarter and Full Year 2017 Results PR Newswire
Feb-09-18 08:00AM  Heska Schedules Fourth Quarter and Year End 2017 Financial Results Conference Call for February 28, 2018 PR Newswire
Jan-30-18 07:30AM  Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-01-17 04:05PM  Heska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departure PR Newswire
Nov-27-17 02:09PM  ETFs with exposure to Heska Corp. : November 27, 2017 Capital Cube
Nov-21-17 12:33PM  Mariko Gordon Starts 5 New Positions in 3rd Quarter GuruFocus.com
Nov-06-17 06:16PM  Edited Transcript of HSKA earnings conference call or presentation 2-Nov-17 3:00pm GMT Thomson Reuters StreetEvents
01:07PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : November 6, 2017 Capital Cube
Nov-03-17 08:34AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : November 3, 2017 Capital Cube +6.09%
Nov-02-17 08:25AM  Heska beats 3Q profit forecasts Associated Press -15.74%
08:00AM  Heska Reports Third Quarter Results PR Newswire
Nov-01-17 08:00AM  Heska Announces 7-Year Agreement with PetVetCare Centers PR Newswire
Oct-31-17 08:00AM  Heska extends product line with new Element COAG Veterinary Analyzer PR Newswire
Oct-30-17 11:57AM  ETFs with exposure to Heska Corp. : October 30, 2017 Capital Cube
Oct-12-17 08:00AM  Heska Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017 PR Newswire
Oct-09-17 11:38AM  ETFs with exposure to Heska Corp. : October 9, 2017 Capital Cube
08:41AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : October 9, 2017 Capital Cube
Oct-06-17 09:04AM  Heska Corp. :HSKA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-18-17 10:01AM  TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion Zacks
Sep-15-17 11:22AM  The Zacks Analyst Blog Highlights: KEMET, Heska, Spirit AeroSystems, American Woodmark and Kraton Zacks
Sep-14-17 05:39PM  4 Biotech Stocks That Show Promise on Sustainable Growth Zacks
09:33AM  Obama-Trump Bull Run is the Second Best Ever: Top 5 Gainers Zacks
Aug-28-17 11:01AM  Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR Zacks
Aug-25-17 10:43AM  5 Efficient Stocks to Buy for a Healthy Portfolio Zacks
Aug-24-17 08:26AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : August 24, 2017 Capital Cube
Aug-23-17 04:11PM  Edited Transcript of HSKA earnings conference call or presentation 31-Jul-17 3:00pm GMT Thomson Reuters StreetEvents
08:00AM  Heska to Present at CL King's 15th Annual Best Ideas Conference 2017 on September 14, 2017 PR Newswire
Aug-16-17 09:16PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : August 17, 2017 Capital Cube
Aug-04-17 09:50AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : August 4, 2017 Capital Cube
Jul-31-17 11:02PM  Heska posts 2Q profit Associated Press
08:00AM  Heska Reports Second Quarter Results PR Newswire
06:45AM  Investor Network: HESKA CORP to Host Earnings Call ACCESSWIRE
Jul-27-17 07:34PM  Heska Adds Growth Capital with $30 Million Credit Agreement with JPMorgan Chase PR Newswire
Jul-20-17 04:05PM  Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10 PR Newswire
Jul-11-17 02:38PM  ETFs with exposure to Heska Corp. : July 11, 2017 Capital Cube
08:00AM  Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017 PR Newswire
Jun-30-17 03:02PM  ETFs with exposure to Heska Corp. : June 30, 2017 Capital Cube
Jun-22-17 08:09AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : June 22, 2017 Capital Cube
Jun-19-17 03:29PM  ETFs with exposure to Heska Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:50AM  Heska Corp. :HSKA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-13-17 09:00AM  Scott Humphrey Joins Heska's Board of Directors PR Newswire
Jun-08-17 02:05PM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
Jun-02-17 08:46AM  Why Heska (HSKA) Could Be Positioned for a Surge Zacks
May-26-17 08:27AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 26, 2017 Capital Cube
May-04-17 04:51PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : May 4, 2017 Capital Cube
08:00AM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
May-03-17 08:46AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 3, 2017 Capital Cube -5.00%
May-02-17 12:33PM  Here's Why Heska Corporation Is Dropping Today Motley Fool -14.21%
08:15AM  Heska posts 1Q profit Associated Press
08:05AM  Investor Network: Heska Corporation to Host Earnings Call Accesswire
08:00AM  Heska Reports First Quarter Results PR Newswire
May-01-17 09:59AM  Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2 Zacks
Apr-28-17 10:43AM  Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up Zacks
09:57AM  Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates Zacks
09:31AM  Align Technology (ALGN) Beats on Q1 Earnings and Revenues Zacks
Apr-27-17 09:03AM  Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1 Zacks
08:00AM  Heska To Present at Four Upcoming Conferences PR Newswire
Apr-26-17 11:10AM  Medical Device Maker Bolts Higher On Earnings In Massive Volume Investor's Business Daily
Apr-25-17 05:19PM  Reminder: Heska Annual Meeting of Stockholders on May 1, 2017 PR Newswire
Apr-20-17 06:07PM  CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up Zacks
09:30AM  Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne Zacks
Apr-19-17 10:38AM  Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III Zacks
07:42AM  Create an Efficient Portfolio with 5 Top Stocks Zacks
Apr-18-17 10:08AM  Bristol-Myers and Nordic Ink Biomarker Collaboration Deal Zacks
09:29AM  Rigel Pharmaceuticals Files NDA for Thrombocytopenia Drug Zacks
Apr-17-17 09:47AM  Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S. Zacks
Apr-13-17 08:58AM  Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe Zacks
08:00AM  Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017 PR Newswire
Apr-12-17 08:00AM  Heska Schedules Annual Meeting of Stockholders for May 1, 2017 PR Newswire
Apr-10-17 05:27PM  Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion Zacks
05:18PM  Roche's Lung Cancer Drug Alecensa Meets Primary Endpoint Zacks
Apr-06-17 09:57AM  Bristol-Myers' (BMY) sBLA For Opdivo Accepted by the FDA Zacks
Apr-05-17 08:35PM  Today's Strong Buy Stocks at New Highs Zacks
03:36PM  Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst Zacks
12:48PM  Roche Announces Positive Data on Lung Cancer Drug Alecensa Zacks
09:10AM  Amedisys (AMED) Poised on Strong Home Health, Risks Remain Zacks
Apr-04-17 12:01PM  Bristol-Myers Announces Data on Immuno-oncology Drug Opdivo Zacks
11:12AM  QIAGEN Releases Favorable GeneReader Results, Expands in NGS Zacks
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; Cloudbank, a Web-based image storage solution; ViewCloud, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Its Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines primarily under the Titanium and MasterGuard brands; biological and pharmaceutical products for other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging. The company sells its products to veterinarians through a field organization and third-party distributors; and trade shows, print advertising, and other distribution relationships. Heska Corporation has product development partnership and licensing agreement with MBio Diagnostics, Inc. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Jul 09Sale110.001,200132,00029,374Jul 11 04:11 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Jun 08Sale106.5075079,87534,873Jun 11 04:30 PM
GORDON G IRWINDirectorJun 08Sale106.183,400361,02516,606Jun 11 04:26 PM
GORDON G IRWINDirectorJun 07Sale103.863,400353,12920,006Jun 11 04:21 PM
GORDON G IRWINDirectorJun 06Sale105.773,400359,61323,406Jun 08 05:10 PM
GORDON G IRWINDirectorJun 05Sale105.663,400359,24026,806Jun 07 04:03 PM
GORDON G IRWINDirectorJun 04Sale105.743,400359,52830,206Jun 06 03:53 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Jun 01Sale108.202,250243,45835,623Jun 01 04:38 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Jun 01Sale108.502,500271,25030,574Jun 01 04:22 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 31Sale107.5050253,965100May 31 04:36 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 31Sale106.803,131334,39132,074May 31 04:36 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.May 30Sale105.731,200126,88137,873May 31 04:42 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 30Sale105.302,869302,10635,205May 31 04:36 PM
Trowbridge Bonnie J.DirectorMay 29Option Exercise28.415,000142,0506,249May 31 04:39 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.May 29Sale102.661,300133,45739,073May 31 04:42 PM
Trowbridge Bonnie J.DirectorMay 29Sale101.015,000505,0381,249May 31 04:39 PM
Eyl Steven M.EVP, Global Sales & MarketingMay 18Sale103.0058259,9469,900Jul 11 04:08 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Dec 28Option Exercise18.3011,000201,30043,119Dec 29 04:43 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Dec 13Option Exercise18.307,000128,10045,128Dec 15 01:57 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 30Sale86.026,500559,12492,446Dec 04 02:40 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 29Sale87.027,025611,28298,946Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 28Sale88.1980070,549105,971Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 27Sale88.54189106,771Nov 29 06:16 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Aug 31Sale102.2182584,32738,114Aug 31 05:28 PM
McMahon JohnVP, Chief Financial OfficerAug 30Option Exercise63.322,608165,1442,676Aug 31 05:26 PM
McMahon JohnVP, Chief Financial OfficerAug 30Sale101.172,608263,85768Aug 31 05:26 PM